This ADIPS Statement summarises currently available Insulin Pump, CGM and Flash Glucose Monitoring (Flash GM) Devices in Australia.
These guidelines have been further updated to be consistent with the WHO guidelines.
Read the ADIPS Consensus Guidelines (Please Note: These guidelines have been modified; November 2014)
This original article has been published in the New England Journal of Medicine - May 5, 2023 and may interest ADIPS members. The authors are a significant group of ADIPS members and it is a key piece of Australian led research. Here is the link
The joint statement from ADIPS, ADS (Australian Diabetes Society), ADEA (Australian Diabetes Educators Association), and DA (Diabetes Australia) is to guide health professionals with the diagnosis of gestational diabetes during the COVID-19 pandemic. The statement was updated on 30 April 2020 after further consultation with ADS, ADEA, DA, RANZCOG and RCPA. Please CLICK HERE to download and view.
The position statement has been developed to inform women who may be at risk of, or who develop, gestational diabetes mellitus (GDM) and also to inform the community, policy makers and health care providers. It is not intended as a clinical guidance document for health professionals. The position statement addresses the diagnosis, management and post-pregnancy care of women who develop GDM. It provides an overview of key issues relating to GDM and its impact and makes recommendations about the care and support women should receive.
You can download this position statement HERE
The Australian Government has developed a new national diabetes strategy. This strategy updates and prioritises the response to diabetes for all governments. Here is a link to the Australian National Diabetes Strategy 2021-2030 - CLICK HERE